124 related articles for article (PubMed ID: 10811289)
1. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
[TBL] [Abstract][Full Text] [Related]
2. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
Tominaga M; Igarashi M; Daimon M; Eguchi H; Matsumoto M; Sekikawa A; Yamatani K; Sasaki H
Endocr J; 1993 Jun; 40(3):343-9. PubMed ID: 7920888
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
[TBL] [Abstract][Full Text] [Related]
5. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
Hevener AL; Reichart D; Janez A; Olefsky J
Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
[TBL] [Abstract][Full Text] [Related]
12. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
Anil Kumar KL; Marita AR
Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone improves insulin-stimulated glucose utilization associated with an increased muscle glycogen content in obese Zucker rats.
Oshida Y; Kako M; Nakai N; Shimomura Y; Li L; Sato J; Ohsawa I; Sato Y
Endocr J; 1999 Oct; 46(5):723-30. PubMed ID: 10670760
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatments for GH-induced insulin resistance.
Sugimoto M; Takeda N; Hattori J; Yoshino K; Nakashima K; Okumura S; Ishimori M; Yasuda K
Endocr J; 1999 Mar; 46 Suppl():S51-3. PubMed ID: 12054120
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Sugiyama Y; Shimura Y; Ikeda H
Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone reduces free fatty acid-induced insulin resistance in perfused rat hindquarter.
Mokuda O; Sakamoto Y
Diabetes Metab; 1998 Sep; 24(4):362-4. PubMed ID: 9805648
[TBL] [Abstract][Full Text] [Related]
19. Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
Weinstein SP; Holand A; O'Boyle E; Haber RS
Metabolism; 1993 Oct; 42(10):1365-9. PubMed ID: 8412752
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of troglitazone on in vivo insulin action in normal rats.
Lee MK; Olefsky JM
Metabolism; 1995 Sep; 44(9):1166-9. PubMed ID: 7666790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
